Kevin Murphy, MD
Allergy & Immunology · Boys Town, NENPI 1326181249
Payments from drug & device makers
Across 1,056 payments — averaging $1025.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$615K
- Sanofi$197K
- Regeneron Healthcare Solutions, Inc.$112K
- Genentech USA, Inc.$64K
- Astrazeneca AB$29K
- Astrazeneca UK Limited$29K
- plus $36K from 22 others
Across 11 payments — averaging $2212.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$17K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- Sanofi$2K
What the payments were for
- Consulting fees$297,90928%
- Speaking & faculty fees$574,47453%
- Grants$2,5000%
- Travel & lodging$183,14217%
- Food & beverage$22,7942%
- Education$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 570 | $614,604 |
| Sanofi | 159 | $197,234 |
| Regeneron Healthcare Solutions, Inc. | 145 | $112,400 |
| Genentech USA, Inc. | 66 | $64,301 |
| Astrazeneca AB | 27 | $29,307 |
| Astrazeneca UK Limited | 7 | $28,815 |
| Pharming Healthcare, Inc. | 24 | $12,068 |
| Regeneron | 4 | $6,952 |
| Amgen | 8 | $5,281 |
| GSK | 9 | $3,351 |
| Novartis | 4 | $2,886 |
| Optinose US, Inc. | 4 | $2,318 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,800 |
| Aero US Inc | 1 | $369 |
| Genentech, Inc. | 5 | $243 |
| Alk-abello, Inc | 3 | $238 |
| Sanofi-aventis U.S. LLC | 2 | $142 |
| Biocryst US Sales Co., LLC | 2 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $53 |
| Kaleo, Inc. | 2 | $39 |
| Spark Therapeutics, Inc. | 1 | $30 |
| Pfizer | 2 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| CSL Behring | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$318,718
- FASENRA$216,025
- AIRSUPRA$199,091
- XOLAIR$50,187
- TEZSPIRE$45,595
- SYMBICORT$21,316
- JOENJA$11,569
- PULMICORT RESPULES$4,280
- NUCALA$3,250
- NO PRODUCT DISCUSSED$2,500
- Xhance$2,250
- AEROGEN SOLO NEBULIZER SYSTEM$737
- AEROGEN USB CONTROLLER SYSTEM$369
- AEROGEN SOLO; AEROGEN ULTRA$369
- BREZTRI$130
- Odactra$104
How this compares
$1,082,676 in reported general payments places this provider in the 90th percentile of 21 allergy & immunology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $77,959 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $21,778 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $20,378 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $5,114 |
| QnaslBeclomethasone Dipropionate | 14 | $4,858 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,387 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,237 |
| Montelukast Sodium | 116 | $878 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $739 |
| Azelastine Hcl | 13 | $493 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $334 |
| Fluticasone Propionate | 22 | $302 |
| Prednisone | 44 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $3,351 | $46,54476 claims |
| AstraZenecaSymbicort | $614,604 | $5,11417 claims |
| Teva Pharmaceuticals USA, Inc.Qnasl | $57 | $4,85814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 21 allergy & immunology providers in Nebraska.
Other allergy & immunology in Boys Town
- Nigar NairBoys Town$206
- Linda FordBellevue$2.4M
- Robert SzalewskiLincoln$1.5M
- Gregory BrooksBellevue$639K
- Jill PooleOmaha$298K
- Roger KobayashiOmaha$278K
- Sara MayOmaha$219K
- Brett KettelhutOmaha$193K
- James TracyOmaha$115K
- Mitchell PitlickOmaha$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.